Presentation
7 March 2022 Equivalent efficacy of indoor daylight and conventional ALA-PDT for treatment of actinic keratosis during winter
Alberto J. Ruiz, Ethan P. M. LaRochelle, Brady Hunt, Kimberley S. Samkoe, Brian W. Pogue, M. Shane Chapman
Author Affiliations +
Abstract
Indoor-daylight photodynamic therapy (PDT) for actinic keratoses (AKs) could overcome the treatment limitations associated with conventional lamp-based PDT and outdoor sunlight treatments. The objective of this study was to compare the AK lesion clearance efficacy of a conventional treatment (30 minute of 5-aminolevulinic acid [ALA] preincubation, followed by 10 minutes of red light) versus indoor daylight treatment (30 minute of ALA pre-incubation, followed by 2 hours of indoor sunlight). A prospective clinical trial was conducted with 43 patients. The results of the study indicate that indoor sunlight-based PDT provides equivalent AK treatment efficacy to a conventional lamp-based regimen while overcoming temperature limitations associated with winter season outdoor sunlight treatments.
Conference Presentation
© (2022) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Alberto J. Ruiz, Ethan P. M. LaRochelle, Brady Hunt, Kimberley S. Samkoe, Brian W. Pogue, and M. Shane Chapman "Equivalent efficacy of indoor daylight and conventional ALA-PDT for treatment of actinic keratosis during winter", Proc. SPIE PC11940, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic and Photobiomodulation Therapy XXX, (7 March 2022); https://doi.org/10.1117/12.2612347
Advertisement
Advertisement
KEYWORDS
Photodynamic therapy

Clinical trials

Back to Top